Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Alkermes plc. (ALKS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Alkermes plc. (ALKS), most recent 12 months reported: revenue $1.67B, net income $66.12M, free cash flow $221.65M. Latest balance sheet on file: liquid cash $656.58M. From SEC filings. Others in Pharmaceutical Preparations: United Therapeutics Corporation · AMNEAL PHARMACEUTICALS, INC. · Royalty Pharma plc · SAREPTA THERAPEUTICS, INC. · Phibro Animal Health Corporation · Indivior Pharmaceuticals, Inc. · MADRIGAL PHARMACEUTICALS, INC. · ACADIA PHARMACEUTICALS INC.

Stock screener

Watchlist